Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pneumonia caused by Nocardia nova].

T Ikeue1, K Ueshima, S Watanabe

  • 1Department of Respiratory Disease, Japan Red Cross Society, Wakayama Medical Center, Wakayama, Japan.

Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society
|October 3, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence, risk factors, and clinical implications of enfortumab vedotin-related cutaneous toxicity in urothelial carcinoma: a large-scale, real-world study in Japan.

ESMO real world data and digital oncology·2026
Same author

Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Search for the Majorana Nature of Neutrinos in the Inverted Mass Ordering Region with KamLAND-Zen.

Physical review letters·2023
Same author

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis.

ESMO open·2022
Same author

Enfortumab vedotin-induced cutaneous adverse events manifesting as miliaria-like eruptions with the presence of keratinocyte apoptosis in clinically intact skin.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib.

ESMO open·2021

This report details a Nocardia nova pneumonia case in Japan. Clarithromycin effectively treated the infection when other antibiotics failed, offering a new treatment option.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Nocardia nova is an opportunistic pathogen that can cause severe infections in immunocompromised individuals.
  • Polymyositis patients on long-term immunosuppressive therapy (steroids, cyclophosphamide) are at increased risk for Nocardia infections.

Observation:

  • A 52-year-old woman with polymyositis presented with bilateral pulmonary nodules, some cavitated.
  • Sputum analysis revealed gram-positive branched organisms, with cultures identifying Nocardia species.
  • The patient developed fever and productive cough, indicative of pneumonia.

Findings:

  • The Nocardia isolate was identified as Nocardia nova.
  • Initial treatment with imipenem and trimethoprim-sulfamethoxazole led to partial recovery.

Related Experiment Videos

  • Subsequent treatment with clarithromycin resulted in near-complete resolution of pulmonary infiltrates.

    • Implications:

    • This case highlights Nocardia nova as a cause of pneumonia in Japan.
    • Clarithromycin demonstrates efficacy as an alternative oral agent for Nocardia pneumonia when standard therapies are ineffective or not tolerated.
    • Early diagnosis and appropriate antibiotic selection are crucial for managing Nocardia infections in immunocompromised patients.